SRS237 - Inhibition of the NLRP3 inflammasome improves functional outcomes and decreases expression of the inflammatory cytokines IL-1b and IL-18 during normothermic machine perfusion of human kidneys

View at publisher Summarise with VIRAT
Authors: Maulik Mehta, Jenna R. DiRito, Serena MacMillan, Sarah A. Hosgood, Michael L. Nicholson
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Background Assembly and activation of the NLRP3 inflammasome is a critical mechanism in renal ischaemia reperfusion injury (IRI). NLRP3 activation leads to caspase-1 dependent release of the pro-inflammatory cytokines IL-1b and IL-18 and pyroptotic cell death. This study investigates the effects of the selective NLRP3 inhibitor MCC950 on renal IRI using normothermic machine perfusion (NMP) as a platform for targeted drug delivery. Methods Dose-response and cytokine release assays were performed using in vitro organ culture. Transplant-declined human kidneys (n = 4 control and n = 4 treatment) were allocated to 4h of NMP using a red cell-based perfusate with or without 100 mM of MCC950. Renal blood flow (RBF) and urine output (UO) were monitored continuously. Renal biopsies taken at the start and end of NMP were studied in an organ culture model of IRI. Results During NMP, MCC950 inhibition of NLRP3 increased RBF and UO (P < 0.050). Perfusate levels of IL-1b and IL-18 and other pro-inflammatory cytokines were decreased in MCC950 treated kidneys (P < 0.050). Organ culture of NMP kidney biopsies submitted to IRI demonstrated that NLRP3 inhibition with MCC950 reduced IL-1b to nearly undetectable levels (P = 0.0002) and significantly reduced IL-18 (P = 0.0373) release into the culture media. Conclusions NLRP3 inflammasome inhibition during NMP reduces renal IRI. The direct delivery of therapies to kidneys during NMP eliminates problem of targeting to the organ of interest and reduces the risk of off-target adverse effects in the recipient. This strategy has potential to better prepare kidneys prior to transplantation and should be evaluated in a clinical trial.

Fields of Study & Subjects

Inflammasome and immune disorders Organ Transplantation Techniques and Outcomes Acute Kidney Injury Research

Publication details

Journal / source
British journal of surgery
Volume
113
Issue
Supplement_2
Publication date
1 March 2026
Language
EN